Fibrocell Science, Inc. Announces Recognition for LAVIV™ (azficel-T) at The 2012 Cell & Gene Therapy Forum, Washington …

EXTON, Pa.--(BUSINESS WIRE)-- Fibrocell Science, Inc. (OTCBB:

FCSC.OB -
News), a biotechnology company focused on the development
of autologous (personalized) cell therapies for aesthetic,
medical and scientific applications, announces that the June
2011 FDA approval of LAVIV™ (azficel-T) for the improvement of
the appearance of “smile line” wrinkles was named the #3 top
story of 2011 in cell and gene therapy and regenerative
medicine at The 2012 Cell & Gene Therapy Forum in
Washington, D.C. The award was voted by The Cell & Gene
Therapy Forum survey responders, comprised of Director-level
and above leaders in the cell and gene therapy and regenerative
medicine industry. The meeting is organized annually by
Phacilitate (www.phacilitate.co.uk),
a specialist in the organization of exclusive events (www.phacilitate.co.uk/cgt)
for leaders from the life sciences community.

“We are delighted and honored that industry leaders attending
The 2012 Cell & Gene Therapy Forum have recognized the FDA
approval of LAVIV and we hope we continue to impress the
industry with our innovations in upcoming years,” said David
Pernock, Fibrocell Science Chairman and CEO. “Fibrocell Science
is committed to exploring the full therapeutic potential of our
personalized fibroblast cellular treatment for use in diverse
medical and aesthetic applications.”

About LAVIV™

Approved on June 21, 2011, LAVIV™ (azficel-T) is the first and
only personalized cell therapy approved by the FDA for
aesthetic use. It is indicated for the improvement of the
appearance of moderate to severe nasolabial fold wrinkles
(“smile lines”), in adults. The patented technology behind
LAVIV is an advanced process that extracts a person’s
collagen-producing fibroblast cells from a small skin sample
and multiplies them in the Fibrocell Science lab. (The collagen
produced by fibroblast cells helps give skin its tone,
structure and overall quality. As people get older, the number
of fibroblasts decreases and collagen breaks down, resulting in
wrinkles and lost skin tone. ) LAVIV is the resulting
formulation of a person’s own fibroblast cells, which is then
injected into “smile line” wrinkles.

LAVIV is now available in major metropolitan areas throughout
the U.S., exclusively through board-certified dermatologists
and plastic surgeons who have been trained by Fibrocell Science
on the treatment process. A list of trained and certified
physicians is available at
http://www.mylaviv.com and will be continually updated as new
physicians are trained and begin offering LAVIV in their
practice.

Important Safety Information About LAVIV™ (azficel-T)

LAVIV is made especially for you from your own skin cells.
Using someone else’s cells can cause a serious reaction. Prior
to injection, confirm with your physician that your information
on the LAVIV vial is correct.

The most common side effects of LAVIV are at the
injection-site, including redness, bruising, swelling, pain,
bleeding, lumps, irritation, and itchiness. In clinical trials
with LAVIV, most injection-site adverse reactions resolved
within one week and most required no treatment.

Your health care provider will help you to decide whether you
are a candidate for LAVIV and may help you avoid some of the
adverse reactions from LAVIV. Before getting LAVIV, tell your
healthcare provider if you have any medical problems including
allergic reactions to any drugs or food, bleeding disorders or
take blood-thinning medicines like aspirin, ibuprofen, or
coumadin, keloids or excessive scarring, skin cancer or any
malignancy, genetic disorders affecting your skin, immune
problems or take medicines that affect your immune system, or
any other illness or medical problem. The full Prescribing
Information for LAVIV includes additional warnings about
adverse reactions that occurred in less than 1% of patients
following LAVIV treatment in clinical trials. Talk to your
healthcare provider about these warnings.

Please tell your healthcare provider if you are allergic to the
antibiotics amphotericin or gentamicin, bovine materials
(products made from cattle), or dimethyl sulfoxide (DMSO). Do
not use LAVIV if you have a skin infection on your face because
LAVIV treatment can make the infection worse.

For more information about LAVIV, please see the Full
Prescribing Information at
http://www.mylaviv.com.

About Fibrocell Science, Inc.

Fibrocell Science, Inc. (OTCBB:
FCSC.OB -
News) is a biotechnology company focused on the development
of regenerative cell therapy for aesthetic, medical and
scientific applications. Fibrocell Science is committed to
advancing the scientific, medical and commercial potential of
autologous skin and tissue, as well as its innovative cellular
processing technology and manufacturing excellence. For
additional information, please visit
http://www.fibrocellscience.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50150198&lang=en

MULTIMEDIA AVAILABLE:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50150198&lang=en

Read more:
Fibrocell Science, Inc. Announces Recognition for LAVIV™ (azficel-T) at The 2012 Cell & Gene Therapy Forum, Washington ...